Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study

Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study

In the last two decades, surgical methods for axillary staging in breast cancer patients have become less extensive, and full axillary lymph node dissection (ALND) is confined to selected patients. In initially node-positive patients undergoing neoadjuvant chemotherapy, however, the optimal manageme...

Full description

Bibliographic Details
Main Authors: Maggie Banys-Paluchowski, Maria Luisa Gasparri, Jana de de Boniface, Oreste Gentilini, Elmar Stickeler, Steffi Hartmann, Marc Thill, Isabel T. Rubio, Rosa Di Di Micco, Eduard-Alexandru Bonci, Laura Niinikoski, Michalis Kontos, Guldeniz Karadeniz Karadeniz Cakmak, Michael Hauptmann, Florentia Peintinger, David Pinto, Zoltan Matrai, Dawid Murawa, Geeta Kadayaprath, Lukas Dostalek, Helidon Nina, Petr Krivorotko, Jean-Marc Classe, Ellen Schlichting, Matilda Appelgren, Peter Paluchowski, Christine Solbach, Jens-Uwe Blohmer, Thorsten Kühn, the AXSANA Study Group
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
neoadjuvant therapy
breast cancer
therapy response
targeted axillary dissection
marked lymph node
Online Access:https://www.mdpi.com/2072-6694/13/7/1565

Internet

https://www.mdpi.com/2072-6694/13/7/1565

Similar Items